These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R, Wahab NA, Yadav MM, Kutty MK. Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [Abstract] [Full Text] [Related]
3. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M. Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406 [Abstract] [Full Text] [Related]
4. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O. Pathol Res Pract; 2006 Mar; 202(8):569-76. PubMed ID: 16828238 [Abstract] [Full Text] [Related]
7. [Cytochemical determination of estrogen receptors in breast tumors]. Winzer KJ, Kranz D, Enzmann G. Zentralbl Chir; 1987 Mar; 112(18):1155-9. PubMed ID: 2825448 [Abstract] [Full Text] [Related]
8. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Latta EK, Tjan S, Parkes RK, O'Malley FP. Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013 [Abstract] [Full Text] [Related]
9. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [Abstract] [Full Text] [Related]
12. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma. MacConmara M, O'Hanlon DM, Kiely MJ, Connolly Y, Jeffers M, Keane FB. Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115 [Abstract] [Full Text] [Related]
13. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM, Cher-Siangang P, Tan PH. Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [Abstract] [Full Text] [Related]
14. Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions. Benz C, Wiznitzer I, Lee SH. Cytometry; 1985 May; 6(3):260-7. PubMed ID: 3996141 [Abstract] [Full Text] [Related]
18. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Bratthauer GL, Saenger JS, Strauss BL. Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199 [Abstract] [Full Text] [Related]
19. Glycoprotein synthesis as a function of epithelial cell arrangement: biosynthesis and release of glycoproteins by human breast and prostate cells in organ culture. Tökés ZA, Dermer GB. J Supramol Struct; 1977 Dec; 7(3-4):515-30. PubMed ID: 211350 [Abstract] [Full Text] [Related]
20. The histopathological evaluation of human breast cancers in correlation with estrogen receptor values. Parl FF, Wagner RK. Cancer; 1980 Jul 15; 46(2):362-7. PubMed ID: 6248193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]